Last reviewed · How we verify
NCT06672562
Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth
NA trial testing Narrative Enhancement and Cognitive Therapy in Bipolar Disorder in 96 participants. Participants enrolled and being followed up; not accepting new ones.
Quick facts
| Lead sponsor | Centre for Addiction and Mental Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Enrollment | 96 |
| Start date | 28 October 2024 |
| Estimated completion | 30 June 2026 |
Drugs / interventions tested
- Narrative Enhancement and Cognitive Therapy
- Usual care
Conditions studied
- Bipolar Disorder — all drugs for Bipolar Disorder →
- Multiple Mental Health Conditions — all drugs for Multiple Mental Health Conditions →
Sponsor
Centre for Addiction and Mental Health — full company profile →
Who can join
Eligibility, any sex, with Bipolar Disorder or Multiple Mental Health Conditions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Narrative enhancement and cognitive therapy for self-stigma among youth with bipolar disorder or multiple mental health conditions: protocol for a pilot randomised basket trial.
Hawke LD, Husain MI, Amartey A, Ma C, et al · · 2025 · cited 1× · PMID 40010812 · DOI 10.1136/bmjopen-2024-096222
Verify or expand the search:
- PubMed search for NCT06672562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bipolar Disorder
Currently open trials in the same condition.
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT06911931 — Visual Perception in Schizophrenia · NA · recruiting
- NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
- NCT07479758 — Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Out · recruiting
- NCT07140913 — A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur · Phase 3 · recruiting
Other Centre for Addiction and Mental Health trials
Trials by the same sponsor.
- NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
- NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
- NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
- NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
- NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06672562 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06672562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing